Akèy › Timè neuroektodermal primitif
Etid klinik pou Timè neuroektodermal primitif ap rekrite nan Etazini
15 etid pou Timè neuroektodermal primitif ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Sep 11, 2026 · NCT07087002HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Ap rekriteFaz 1/2
Jiska laj 26 · Tout sèks · Mizajou Sep 3, 2026 · NCT06465199B7-H3.CD28Z.CART in CNS Neoplasms
Ap rekriteFaz 1
Laj 2 a 21 · Tout sèks · Mizajou Sep 3, 2026 · NCT07390539C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Ap rekriteFaz 1
12 Months – 25 Years · Tout sèks · Mizajou Aug 3, 2026 · NCT04099797Embryonal Tumor With Multilayered Rosettes
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Jun 29, 2026 · NCT06861244Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Jun 17, 2026 · NCT06193759ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 2, 2026 · NCT04794686Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT04074135Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Ap rekriteFaz 1
Laj 1 a 26 · Tout sèks · Mizajou Apr 13, 2026 · NCT04185038Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Ap rekriteFaz 1
Laj 3 a 25 · Tout sèks · Mizajou Jan 9, 2026 · NCT05106296Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT04541082Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Ap rekriteFaz 1
7 Months – 21 Years · Tout sèks · Mizajou Oct 16, 2025 · NCT02508038Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou May 23, 2019 · NCT03048266Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.